Delisting riskPopularity #4,337
IM Cannabis (IMCC)
Importer, brand manager and pharmacy distributor of medical cannabis in Israel and Germany.
$3.85
vs last close+0.76 (+24.80%)
In millions of USD, except per-share figures · converted from CAD at the latest rate
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 8 | 9 | 10 | 10 | 9 | 9 | 9 | 10 | 8 | 6 | 5 |
| Cost of revenue | 7 | 7 | 7 | 10 | 8 | 8 | 6 | 7 | 8 | 8 | 5 | 4 |
| Gross profit | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 1 | 1 |
| 3 | 4 | 5 | −1 | 2 | 16 | 2 | 3 | 5 | 2 | 2 | 3 | |
| 3 | 2 | 3 | 3 | 3 | 1 | 2 | 3 | 3 | 1 | 2 | 3 | |
| Selling & marketing | 2 | −4 | 2 | 1 | 1 | −2 | 1 | 1 | 1 | −2 | 1 | 1 |
| General & administrative | 2 | 6 | 2 | 2 | 2 | 3 | 1 | 2 | 2 | 3 | 1 | 2 |
| Other expenses | 0 | 2 | 2 | −4 | −1 | 15 | 0 | 0 | 2 | 1 | 0 | 0 |
| Operating income | −2 | −4 | −4 | 2 | 1 | −14 | 0 | 0 | −3 | −2 | −1 | −1 |
| 0 | 2 | 0 | −5 | −1 | 13 | 0 | 0 | 0 | −2 | −1 | −2 | |
| Interest income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2 |
| Other non-operating income | 3 | −5 | 0 | 4 | 1 | −13 | 0 | −1 | 0 | 0 | 0 | 0 |
| Income before tax | −1 | −2 | −4 | −3 | −1 | −1 | 0 | 0 | −3 | −4 | −2 | −3 |
| Income tax expense | 0 | 1 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −2 | −3 | −4 | −2 | −1 | −1 | 0 | 0 | −3 | −4 | −2 | −3 |
| Net income | −2 | −2 | −4 | −2 | −1 | −1 | 0 | 0 | −3 | −4 | −2 | −3 |
| EPS, basic | −$0.68 | $0.00 | −$53.78 | −$29.02 | −$8.75 | $0.00 | $1.92 | −$1.92 | −$16.01 | $0.00 | −$8.11 | −$0.33 |
| EPS, diluted | −$0.68 | $0.00 | −$53.78 | −$29.02 | −$8.75 | $0.00 | $1.92 | −$1.92 | −$16.01 | $0.00 | −$8.11 | −$0.33 |
| Weighted average shares, basic | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Weighted average shares, diluted | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| EBITDA | −1 | 1 | −3 | −2 | 0 | −1 | 0 | 1 | −3 | −2 | −1 | −1 |
| Depreciation & amortization | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −2 | 1 | −4 | −2 | −1 | −1 | 0 | 1 | −3 | −2 | −1 | −1 |